Google
×

Bortezomib

Brand name: Velcade
It can treat multiple myeloma and mantle cell lymphoma.
Brands: Velcade
Availability: Prescription needed
Pregnancy: Consult a doctor
Alcohol: No known interactions with light drinking
Consult a doctor for medical advice Sources: First Databank and others. Learn more

People also ask
Velcade® (bortezomib) is an injectable anti-cancer agent used in various stages of multiple myeloma. See potential side effects and other information.
Jun 30, 2014 · Velcade® represents a new type of anticancer drug called proteasome inhibitors. It has shown promise in the treatment of multiple myeloma, ...
Sep 1, 2023 · Bortezomib is a type of targeted cancer drug. It is also known as Velcade. It is a treatment for myeloma and mantle cell lymphoma. You pronounce ...
Bortezomib is FDA-approved for use in the initial treatment of multiple myeloma in combination with cyclophosphamide and dexamethasone.
The introduction of bortezomib, a novel first-in-class proteasome inhibitor, has been a major break through in the treatment of multiple myeloma.
Velcade (bortezomib) is a brand-name prescription drug. It's used to treat multiple myeloma and mantle cell lymphoma. Learn about side effects and more.
This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). It works by slowing or stopping the growth of cancer ...
USES: This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). It works by slowing or stopping the growth of ...
Oct 25, 2023 · Official answer: Overview Velcade has been shown in clinical studies to help people with previously untreated multiple myeloma live...
Nov 16, 2017 · The Food and Drug Administration has approved Velcade to treat a type of cancer called multiple myeloma. Velcade should only be used in ...